Evidence map›Paper›PMID 37623046›Full record

ArticleJournal of medicinal chemistry2023

Multiobjective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex.

Hongsong Feng, Rui Wang, Chang-Guo Zhan, Guo-Wei Wei

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Hongsong FengDepartment of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States.
Rui WangDepartment of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0000-0002-7402-6372
Chang-Guo ZhanDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40506, United States.ORCID 0000-0002-4128-7269
Guo-Wei WeiDepartment of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States.ORCID 0000-0002-5781-2937

Funding

AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodiesR01AI164266 · NIAID · UNIVERSITY OF GEORGIA · PI Guowei Wei, YONG-HUI ZHENG · 2022 to 2026
$2.7M
Discovery-Driven Mathematics and Artificial Intelligence for Biosciences and Drug DiscoveryR35GM148196 · NIGMS · UNIVERSITY OF GEORGIA · PI Guowei Wei · 2023 to 2026
$1.5M
Synergistic integration of topology and machine learning for the predictions of protein-ligand binding affinities and mutation impactsR01GM126189 · NIGMS · MICHIGAN STATE UNIVERSITY · PI WEI, GUOWEI · 2018 to 2021
$1.4M
NIAID NIH HHS R01 AI164266NIGMS NIH HHS R01 GM126189NIGMS NIH HHS R35 GM148196
6 · The paper itself

Abstract

Opioid use disorder (OUD) has emerged as a significant global public health issue, necessitating the discovery of new medications. In this study, we propose a deep generative model that combines a stochastic differential equation (SDE)-based diffusion model with a pretrained autoencoder. The molecular generator enables efficient generation of molecules that target multiple opioid receptors, including mu, kappa, and delta. Additionally, we assess the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of the generated molecules to identify druglike compounds. We develop a molecular optimization approach to enhance the pharmacokinetic properties of some lead compounds. Advanced binding affinity predictors were built using molecular fingerprints, including autoencoder embeddings, transformer embeddings, and topological Laplacians. Our process yields druglike molecules that can be used in highly focused experimental studies to further evaluate their pharmacological effects. Our machine learning platform serves as a valuable tool for designing effective molecules to address OUD.

Indexed as

Machine LearningOpioid-Related DisordersDiffusionHumansReceptors, OpioidReceptors, Opioid

Identifiers

PMID37623046
PMCPMC11037444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.